News Sharing
For sharing news, please enter the email address of you and the receiver, then press SEND button.*Mandatory Fields
Receiver*
Enter email addresses, separated by semicolon (;). E.g. a@a.com;b@b.com
Your email address*
 Content Sharing
CN Approval of AI Products from Apple, Alibaba Delayed amid Tense US-CN Relations
The Cyberspace Administration of China has delayed the approval of applications for AI-based products from Apple (AAPL.US) and BABA-W (09988.HK), the Financial Times reported on We...
Reset
Send
The window will close in 5 seconds
CN Approval of AI Products from Apple, Alibaba Delayed amid Tense US-CN Relations
Close
Recommend
43
Positive
66
Negative
44
 
SHORT SELL
 
STOCK INFO

The Cyberspace Administration of China has delayed the approval of applications for AI-based products from Apple (AAPL.US)      and BABA-W (09988.HK)  -1.700 (-1.437%)    Short selling $1.71B; Ratio 19.496%   , the Financial Times reported on Wednesday, citing sources familiar with the matter.

According to the report, the decision by China's internet watchdog to postpone the approval process was primarily related to intensifying trade relations with the US.

Related NewsBOCI Lists Actively-Traded Stocks for CN-HK Southbound Link YTD (Table)
China previously accused the US of violating the Geneva trade consensus and cited Washington's decision to impose restrictions on chip and semiconductor exports as an example of hostile actions infringing on China's national interests.
(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2025-06-06 16:25.) (Real-time Streaming US Stocks Quote; Except All OTC quotes are at least 15 minutes delayed.)

AAStocks Financial News
Copyright(C) AASTOCKS.com Limited 2000. All rights reserved.
Disclaimer: AASTOCKS.com Ltd, HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the Information provided but do not guarantee its accuracy or reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.